A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis

Clinical trial NCT07230353 · RECRUITING

Trial details

NCT number: NCT07230353
Sponsor: Xencor, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2025-10-21
Primary completion: 2028-06-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.